<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>
<channel>
	<title>Comentarios en: AutoTB: audience favorite Global Entrepreneurship Competition</title>
	<atom:link href="http://blog.hitbarcelona.com/autotb-audience-favorite-global-entrepreneurship-competition/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.hitbarcelona.com/autotb-audience-favorite-global-entrepreneurship-competition/#utm_source=feed&amp;utm_medium=feed&amp;utm_campaign=feed</link>
	<description>The global gathering where innovation drives the future</description>
	<pubDate>Thu, 17 May 2012 11:19:28 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>Por: Ciaran Malik</title>
		<link>http://blog.hitbarcelona.com/autotb-audience-favorite-global-entrepreneurship-competition/comment-page-1/#comment-909</link>
		<dc:creator>Ciaran Malik</dc:creator>
		<pubDate>Sat, 04 Jul 2009 13:28:20 +0000</pubDate>
		<guid isPermaLink="false">http://blog.hitbarcelona.com/?p=197#comment-909</guid>
		<description>This looks really good, I think its well thought out and a lot of consideration has gone to the end users, especially those most in need. Good luck.</description>
		<content:encoded><![CDATA[<p>This looks really good, I think its well thought out and a lot of consideration has gone to the end users, especially those most in need. Good luck.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Por: émilie laporte</title>
		<link>http://blog.hitbarcelona.com/autotb-audience-favorite-global-entrepreneurship-competition/comment-page-1/#comment-858</link>
		<dc:creator>émilie laporte</dc:creator>
		<pubDate>Mon, 22 Jun 2009 18:55:08 +0000</pubDate>
		<guid isPermaLink="false">http://blog.hitbarcelona.com/?p=197#comment-858</guid>
		<description>It looks quite powerful, good luck guys I hope it gets somewhere!</description>
		<content:encoded><![CDATA[<p>It looks quite powerful, good luck guys I hope it gets somewhere!</p>
]]></content:encoded>
	</item>
	<item>
		<title>Por: Ian Marsh</title>
		<link>http://blog.hitbarcelona.com/autotb-audience-favorite-global-entrepreneurship-competition/comment-page-1/#comment-534</link>
		<dc:creator>Ian Marsh</dc:creator>
		<pubDate>Tue, 16 Jun 2009 19:19:31 +0000</pubDate>
		<guid isPermaLink="false">http://blog.hitbarcelona.com/?p=197#comment-534</guid>
		<description>I am impressed by the project's noble aim, its intelligent identification of a major pain point in TB incidence (i.e. diagnostics) and by the calibre and commitment of the team. Good luck guys!</description>
		<content:encoded><![CDATA[<p>I am impressed by the project&#8217;s noble aim, its intelligent identification of a major pain point in TB incidence (i.e. diagnostics) and by the calibre and commitment of the team. Good luck guys!</p>
]]></content:encoded>
	</item>
	<item>
		<title>Por: Seema Kairam</title>
		<link>http://blog.hitbarcelona.com/autotb-audience-favorite-global-entrepreneurship-competition/comment-page-1/#comment-329</link>
		<dc:creator>Seema Kairam</dc:creator>
		<pubDate>Mon, 15 Jun 2009 22:51:19 +0000</pubDate>
		<guid isPermaLink="false">http://blog.hitbarcelona.com/?p=197#comment-329</guid>
		<description>AutoTB seems to be bring a 21st century approach to a generations' old problem. The most exciting part about this approach to the TB epidemic is the way this team is looking at the problem holistically. Not only are they re-examining the science behind testing for the disease, but also focusing on the importance of accessibility and integrating the test into the existing healthcare structures.</description>
		<content:encoded><![CDATA[<p>AutoTB seems to be bring a 21st century approach to a generations&#8217; old problem. The most exciting part about this approach to the TB epidemic is the way this team is looking at the problem holistically. Not only are they re-examining the science behind testing for the disease, but also focusing on the importance of accessibility and integrating the test into the existing healthcare structures.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Por: BroccoliProject</title>
		<link>http://blog.hitbarcelona.com/autotb-audience-favorite-global-entrepreneurship-competition/comment-page-1/#comment-306</link>
		<dc:creator>BroccoliProject</dc:creator>
		<pubDate>Mon, 15 Jun 2009 21:46:31 +0000</pubDate>
		<guid isPermaLink="false">http://blog.hitbarcelona.com/?p=197#comment-306</guid>
		<description>I think there is great synergy for working with AutoTB and best wishes for the event.

MaZ</description>
		<content:encoded><![CDATA[<p>I think there is great synergy for working with AutoTB and best wishes for the event.</p>
<p>MaZ</p>
]]></content:encoded>
	</item>
	<item>
		<title>Por: CY Ong</title>
		<link>http://blog.hitbarcelona.com/autotb-audience-favorite-global-entrepreneurship-competition/comment-page-1/#comment-225</link>
		<dc:creator>CY Ong</dc:creator>
		<pubDate>Mon, 15 Jun 2009 14:13:10 +0000</pubDate>
		<guid isPermaLink="false">http://blog.hitbarcelona.com/?p=197#comment-225</guid>
		<description>On first glance, AutoTB captures the attention and imagination of the public for reasons that have been stated elsewhere. Well done! However, on closer examination of the blurb given, there are overstatements that, while the general public may not catch, do seem worrying. Sputum microscopy specificity is normally near 95-99%% (even in African countries, no insult implied here - in fact, this should be the case because the large number of positives results in better "operator training"). Little room for improvement here. And malaria - true it is an infectious disease; not bacterial though. More importantly, the main advantage AutoTB might have in making an actual impact on TB in the developing world is the SPEED of diagnosis - many patients are not captured in pre-existing programs because of the delays in diagnosis leading to patients being lost to follow up and treatment. Keep in mind that currently healthy individuals can become infected and missed patients can be re-screened in the future on clinical indication (perhaps implying a need for shorter interval screening in high risk populations - TB doesn't kill immediately after all). If AutoTB's technology can allow large volume processing (and permitting economical re-screening of individuals) within health budget constraints, this will certainly have an impact on the absolute number of TB patients treated, over and above what any marginal increase in sensitivity may bring. I look forward to seeing what AutoTB's technology is actually capable of.</description>
		<content:encoded><![CDATA[<p>On first glance, AutoTB captures the attention and imagination of the public for reasons that have been stated elsewhere. Well done! However, on closer examination of the blurb given, there are overstatements that, while the general public may not catch, do seem worrying. Sputum microscopy specificity is normally near 95-99%% (even in African countries, no insult implied here - in fact, this should be the case because the large number of positives results in better &#8220;operator training&#8221;). Little room for improvement here. And malaria - true it is an infectious disease; not bacterial though. More importantly, the main advantage AutoTB might have in making an actual impact on TB in the developing world is the SPEED of diagnosis - many patients are not captured in pre-existing programs because of the delays in diagnosis leading to patients being lost to follow up and treatment. Keep in mind that currently healthy individuals can become infected and missed patients can be re-screened in the future on clinical indication (perhaps implying a need for shorter interval screening in high risk populations - TB doesn&#8217;t kill immediately after all). If AutoTB&#8217;s technology can allow large volume processing (and permitting economical re-screening of individuals) within health budget constraints, this will certainly have an impact on the absolute number of TB patients treated, over and above what any marginal increase in sensitivity may bring. I look forward to seeing what AutoTB&#8217;s technology is actually capable of.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Por: Nick (SIFE Aston)</title>
		<link>http://blog.hitbarcelona.com/autotb-audience-favorite-global-entrepreneurship-competition/comment-page-1/#comment-221</link>
		<dc:creator>Nick (SIFE Aston)</dc:creator>
		<pubDate>Mon, 15 Jun 2009 13:59:37 +0000</pubDate>
		<guid isPermaLink="false">http://blog.hitbarcelona.com/?p=197#comment-221</guid>
		<description>Looks like a fantastic idea! Good Luck!</description>
		<content:encoded><![CDATA[<p>Looks like a fantastic idea! Good Luck!</p>
]]></content:encoded>
	</item>
	<item>
		<title>Por: Chris Andreou</title>
		<link>http://blog.hitbarcelona.com/autotb-audience-favorite-global-entrepreneurship-competition/comment-page-1/#comment-218</link>
		<dc:creator>Chris Andreou</dc:creator>
		<pubDate>Mon, 15 Jun 2009 13:18:16 +0000</pubDate>
		<guid isPermaLink="false">http://blog.hitbarcelona.com/?p=197#comment-218</guid>
		<description>This sounds awesome! I not only hope Auto TB wins the competition but ultimately that the technology can be used to save lives and helps tackle the spread of the disease.</description>
		<content:encoded><![CDATA[<p>This sounds awesome! I not only hope Auto TB wins the competition but ultimately that the technology can be used to save lives and helps tackle the spread of the disease.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Por: Jamie Cordes</title>
		<link>http://blog.hitbarcelona.com/autotb-audience-favorite-global-entrepreneurship-competition/comment-page-1/#comment-144</link>
		<dc:creator>Jamie Cordes</dc:creator>
		<pubDate>Sat, 13 Jun 2009 21:40:09 +0000</pubDate>
		<guid isPermaLink="false">http://blog.hitbarcelona.com/?p=197#comment-144</guid>
		<description>Its conscientious approach of targeting such a dire global need sets AutoTB apart from its competitors. Others should learn from its target of tackling an epidemic too often passed over when it comes to Western research and funding. In addition, its cooperative business ethic is geared to its market. Too many others maintain arcane and irresponsible expectations of developing countries footing the bill for overpriced Western technology.</description>
		<content:encoded><![CDATA[<p>Its conscientious approach of targeting such a dire global need sets AutoTB apart from its competitors. Others should learn from its target of tackling an epidemic too often passed over when it comes to Western research and funding. In addition, its cooperative business ethic is geared to its market. Too many others maintain arcane and irresponsible expectations of developing countries footing the bill for overpriced Western technology.</p>
]]></content:encoded>
	</item>
	<item>
		<title>Por: Randy Karns</title>
		<link>http://blog.hitbarcelona.com/autotb-audience-favorite-global-entrepreneurship-competition/comment-page-1/#comment-141</link>
		<dc:creator>Randy Karns</dc:creator>
		<pubDate>Sat, 13 Jun 2009 19:44:43 +0000</pubDate>
		<guid isPermaLink="false">http://blog.hitbarcelona.com/?p=197#comment-141</guid>
		<description>Developing a powerful tool to diagnose and treat such a widespread and devastating disease is a critical mission accepted by AutoTB.  Innovations of this kind allows hope and a future for millions of people around the world and allows the large philanthropic organizations to provide targeted investments in solving this human problem.</description>
		<content:encoded><![CDATA[<p>Developing a powerful tool to diagnose and treat such a widespread and devastating disease is a critical mission accepted by AutoTB.  Innovations of this kind allows hope and a future for millions of people around the world and allows the large philanthropic organizations to provide targeted investments in solving this human problem.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

